Two Sigma Investments, LP Albireo Pharma, Inc. Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $1.49 Million - $1.95 Million	-54,292 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $4.26 Million - $5.43 Million	-147,323 Reduced 73.07%	54,292 $39.4 Million
Q1 2021 May 17, 2021	SELL	$32.03 - $42.85 $1.41 Million - $1.89 Million	-44,139 Reduced 17.96%	201,615 $7.11 Million
Q4 2020 Feb 16, 2021	BUY	$31.56 - $42.16 $2.86 Million - $3.82 Million	90,696 Added 58.49%	245,754 $9.22 Million
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $2.76 Million - $4.95 Million	119,076 Added 330.93%	155,058 $5.17 Million
Q2 2020 Aug 14, 2020	BUY	$14.82 - $29.92 $62,999 - $127,189	4,251 Added 13.4%	35,982 $953,000
Q1 2020 May 15, 2020	SELL	$11.67 - $27.23 $64,453 - $150,391	-5,523 Reduced 14.83%	31,731 $519,000
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $66,038 - $113,030	3,903 Added 11.7%	37,254 $947,000
Q3 2019 Nov 14, 2019	BUY	$20.0 - $31.88 $211,340 - $336,875	10,567 Added 46.38%	33,351 $667,000
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $698,785 - $862,602	22,784 New	22,784 $735,000
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $891,675 - $1.12 Million	-30,443 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $879,802 - $1.14 Million	30,443 New	30,443 $1.08 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.